Following Geratherm Medical AG's 20% stake in BIOThermare, a young company that produces environmentally friendly cold/warm compresses with a patented algae gel filling, another update was published by ResearchHub.

The investment in BIOThermare shows the first steps in the implementation of a revised strategy with active portfolio management and a shift towards consumer-oriented MedTech investments.

The innovative cold-warm compress has now been successfully launched and is available in 27 countries via the official BIOThermare online store. Geratherm will use its resources to support the international distribution of BIOThermare products. The target price remains unchanged at EUR 7.00.

You can read the entire report on Research Hub in the digital coverage of Geratherm Medical.

Alternatively, you can find the update as a PDF file here.